This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cha Biotech Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Hyun-Seob Lee in Neural Progenitor Cell Proliferation
Introduction
Hyun-Seob Lee is a notable inventor based in Namyangju-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the proliferation of neural progenitor cells. His work aims to advance treatments for neurological diseases, showcasing the potential of innovative medical solutions.
Latest Patents
Hyun-Seob Lee holds a patent for a method for proliferating neural progenitor cells and a composition for treating neurological diseases containing these proliferated cells. The patent describes a method that involves culturing fetal neural progenitor cells under hypoxic conditions and/or in a medium containing tocopherol, tocopherol acetate, or a mixture thereof. This innovative approach has demonstrated improved cell proliferation rates, which is crucial for the mass production of neural stem cells. The implications of this invention are significant, as the proliferated neural progenitor cells are expected to be utilized in treating various neurological diseases.
Career Highlights
Hyun-Seob Lee is associated with Cha Biotech Co., Ltd., where he continues to develop his research and innovations. His work is pivotal in the biotechnology sector, particularly in enhancing the understanding and application of neural progenitor cells in medical treatments.
Collaborations
Hyun-Seob Lee collaborates with esteemed colleagues, including Jisook Moon and Yeon-Ho Shin. Their combined expertise contributes to the advancement of research in the field of neural progenitor cells and their applications.
Conclusion
Hyun-Seob Lee's innovative work in the proliferation of neural progenitor cells represents a significant advancement in biotechnology. His contributions have the potential to transform the treatment landscape for neurological diseases, highlighting the importance of continued research and innovation in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile